The Hidden Cost: How Poor Blood Smears Affect Patient Care and the Lab's Bottom Line
Oct 19, 2026
The peripheral blood smear remains a foundational, indispensable tool in hematology, offering a microscopic window into a patient's cellular health. It's essential for diagnosing everything from acute leukemia and malaria to various anemias. Yet, a surprisingly high number of blood smears are compromised during the pre-analytical phase—the stage before the test is actually performed—creating a ripple effect of incorrect diagnoses, delayed patient care, and significant financial burdens.
The Cost of Error: Delayed Diagnosis and Patient Harm
When a blood smear is poorly made (e.g., it is too thick, unevenly spread, or has artifacts from clotted blood), it becomes incredibly difficult for laboratory professionals to accurately identify critical cellular abnormalities. These issues are generally categorized as pre-analytical errors, which consistently account for the vast majority of all laboratory errors.
Impact on Patient Safety: Research indicates that the extra-analytical phases (pre- and post-analytical) are the largest sources of error, with the pre-analytical phase accounting for as much as 46% to 68% of total laboratory errors across various studies
(Clinical Chemistry and Laboratory Medicine, 2006).
. Critically, up to 26% of these pre-analytical errors can have detrimental effects on patient care, contributing to unnecessary investigations, inappropriate treatments, and longer hospital stays
(Clinical Biochemistry, 2013).Delayed Diagnosis: A poor-quality smear can obscure the presence of key features like blast cells (leukemia) or parasites (malaria). This necessitates a redraw, re-smear, and re-stain, wasting precious time when a patient's condition, such as sepsis or acute anemia, demands immediate action.
Statistical Snapshot: The Error Rate
While published literature often focuses on overall sample rejection rates, which include issues like clotting and inadequate volume, these errors directly prevent the preparation of a diagnostic blood smear.
Overall Pre-analytical Error Rate: Studies in hematology laboratories have reported the frequency of pre-analytical errors to range from approximately 0.37% to 6.61% of all samples received (Clinical Chemistry, 2025).
Common Culprits: The most frequent errors that compromise the ability to prepare a good smear are clotted samples and inadequate sample volume (due to improper blood-to-anticoagulant ratios), often stemming from poor phlebotomy technique or insufficient mixing (CLSI; Biochemia, 2026; Blood Cells: A Practical Guide, 2015).
A single analysis of hematology samples identified clotted specimens as the most common error, accounting for up to 73.84% of pre-analytical issues in some settings (International Journal of Medical Laboratory, 2024).
The Financial Drain on Labs
Every rejected sample or request for a re-draw translates directly into wasted resources, increasing the financial burden on the laboratory and the healthcare system.
Wasted Personnel Time: A pre-analytical error triggers a cascade of time-consuming re-work: the phlebotomist must spend time collecting a new sample, and the technologist must accession, prepare, and stain a new slide. This diverts skilled personnel from analyzing other critical patient samples, decreasing the lab's overall productivity.
Increased Costs: The cost associated with pre-analytical errors extends beyond mere consumables. When considering both direct costs (re-sampling, re-testing, labor) and indirect costs (treating safety failures, extended hospital stays), pre-analytical errors are estimated to account for a significant portion of healthcare budgets. In a pediatric setting, one study estimated the annual cost of pre-analytical errors to be over [$84,900] for a hospital with 54,040 blood drawings, with personnel costs representing the largest fraction of that total (PLoS ONE, 2023).
To mitigate this "silent epidemic," laboratories must focus intensively on standardized collection procedures, robust staff training, and continuous quality indicator monitoring—turning an inefficient cost center into an optimized partner in rapid and accurate patient diagnosis.
Learn more about the RapidSmear here.